VANCOMYCIN HYDROCHLORIDE 513 mg/mg (Vancomycin Hydrochloride INJECTION, POWDER, FOR SOLUTION) 513 mg/mg

Vancomycin Hydrochloride 513 mg/mg is an injectable powder for solution used for severe bacterial infections. This antibiotic is available in 10 vials per package, suitable for intravenous or oral administration.

Strength

513 mg/mg

Pack Size

10 VIAL in 1 PACKAGE (0143-9161-10) / 513 mg in 1 VIAL (0143-9161-01)

Manufacturer / TM Owner

HIKMA PHARMACEUTICALS USA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vancomycin Hydrochloride is primarily used to treat serious bacterial infections, including those resistant to other antibiotics. It is often prescribed for infections affecting the bloodstream, skin, bones, and heart. This medication is also used for infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

Side Effects

Common effects of Vancomycin Hydrochloride may include redness or pain at the injection site, nausea, and kidney problems. Some individuals may experience hearing loss or allergic reactions. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Vancomycin Hydrochloride should be handled with care, ensuring proper storage and preparation. It is important to follow healthcare provider instructions for administration. Monitor for signs of allergic reactions or other adverse effects. Do not use if you have a known allergy to vancomycin.

Avoid Interactions

Vancomycin Hydrochloride may interact with other medications, including certain antibiotics, diuretics, and drugs that affect kidney function. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Vancomycin Hydrochloride is used to treat severe bacterial infections, including those resistant to other antibiotics.

Vancomycin Hydrochloride is available as an injectable powder for solution, which can be administered intravenously or orally.

Common side effects may include redness or pain at the injection site, nausea, and kidney problems.

Yes, Vancomycin Hydrochloride is often prescribed for infections caused by methicillin-resistant Staphylococcus aureus (MRSA).

Handle with care, follow healthcare provider instructions, and monitor for allergic reactions or other adverse effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.